Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 8/2019

01-08-2019 | Care | Health Services Research and Global Oncology

Palliative Care and Symptom Burden in the Last Year of Life: A Population-Based Study of Patients with Gastrointestinal Cancer

Authors: Shaila J. Merchant, MSc, MHSc, MD, FRCSC, FACS, Susan B. Brogly, PhD, Christopher M. Booth, MD, Craig Goldie, MD, Sulaiman Nanji, MD, PhD, Sunil V. Patel, MSc, MD, Katherine Lajkosz, MSc, Nancy N. Baxter, MD, PhD

Published in: Annals of Surgical Oncology | Issue 8/2019

Login to get access

Abstract

Introduction

The symptom profile in cancer patients and the association between palliative care (PC) and symptoms has not been studied in the general population. We addressed these gaps in gastrointestinal (GI) cancer patients in the final year of life.

Methods

Patients dying of esophageal, gastric, colon, and anorectal cancers during 2003–2015 were identified. Symptom scores were recorded in the year before death using the Edmonton Symptom Assessment System (ESAS), which includes scores from 0 to 10 in nine domains. Symptom severity was categorized as none–mild (≤ 3) or moderate–severe (≥ 4–10). Adjusted associations between outpatient PC and moderate–severe ESAS scores were determined, and the effect of PC initiation on ESAS scores was estimated.

Results

The cohort included 11,242 patients who died (esophageal [17%], gastric [20%], colon [38%], and anorectal [26%] cancers). Fifty percent experienced moderate–severe scores in tiredness, lack of well-being, and lack of appetite earlier (weeks 18 to 12 before death), whereas 50% experienced moderate–severe scores in drowsiness, pain, and shortness of breath later (weeks 5 to 2 before death) in the disease course. Outpatient PC was associated with an increased likelihood of moderate–severe scores in all domains, with the highest score in pain (odds ratio [OR] 1.86, 95% confidence interval [CI] 1.68–2.05). In PC-naïve patients with moderate–severe scores, initiation of outpatient PC was associated with a 1- to 3-point decrease in subsequent scores, with the greatest reductions in pain (OR − 1.91, 95% CI − 2.11 to − 1.70) and nausea (OR − 3.01, 95% CI − 3.31 to − 2.71).

Conclusion

GI cancer patients experience high symptom burden in the final year of life. Outpatient PC initiation is associated with a decrease in symptoms.
Appendix
Available only for authorised users
Literature
1.
Seow H, Barbera L, Sutradhar R, Howell D, Dudgeon D, Atzema C, et al. Trajectory of performance status and symptom scores for patients with cancer during the last 6 months of life. J Clin Oncol. 2011;29(9):1151–8.CrossRefPubMed
2.
Barbera L, Seow H, Howell D, Sutradhar R, Earle C, Liu Y, et al. Symptom burden and performance status in a population-based cohort of ambulatory cancer patients. Cancer. 2010;116(24):5767–76.CrossRefPubMed
3.
Bubis LD, Davis L, Mahar A, Barbera L, Li Q, Moody L, et al. Symptom burden in the first year after cancer diagnosis: an analysis of patient-reported outcomes. J Clin Oncol. 2018;36(11):1103–11.CrossRefPubMed
4.
Wen FH, Chen JS, Chou WC, Hsieh CH, Chang WC, Shen WC, et al. Quality of life and psychological distress are differentially associated with distinct symptom-functional states in terminally ill cancer patients’ last year of life. Psychooncology. 2018;27(9):2111–8.CrossRefPubMed
5.
Wilson KG, Chochinov HM, Skirko MG, Allard P, Chary S, Gagnon PR, et al. Depression and anxiety disorders in palliative cancer care. J Pain Symptom Manag. 2007;33(2):118–29.CrossRef
6.
Brooks GA, Abrams TA, Meyerhardt JA, Enzinger PC, Sommer K, Dalby CK, et al. Identification of potentially avoidable hospitalizations in patients with GI cancer. J Clin Oncol. 2014;32(6):496–503.CrossRefPubMedPubMedCentral
7.
Barbera L, Atzema C, Sutradhar R, Seow H, Howell D, Husain A, et al. Do patient-reported symptoms predict emergency department visits in cancer patients? A population-based analysis. Ann. Emerg Med. 2013;61(4):427–37.CrossRefPubMed
8.
Hui D, Bruera E. The edmonton symptom assessment system 25 years later: past, present, and future developments. J Pain Symptom Manag. 2017;53(3):630–43.CrossRef
9.
Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7(2):6–9.CrossRefPubMed
10.
Chang VT, Hwang SS, Feuerman M. Validation of the edmonton symptom assessment scale. Cancer. 2000;88(9):2164–71.CrossRefPubMed
11.
Pereira J, Green E, Molloy S, Dudgeon D, Howell D, Krzyzanowska MK, et al. Population-based standardized symptom screening: cancer care Ontario’s edmonton symptom assessment system and performance status initiatives. J Oncol Pract. 2014;10(3):212–4.CrossRefPubMed
12.
Seow H, Sussman J, Martelli-Reid L, Pond G, Bainbridge D. Do high symptom scores trigger clinical actions? An audit after implementing electronic symptom screening. J Oncol Pract. 2012;8(6):e142–8.CrossRefPubMedPubMedCentral
13.
Okafor PN, Stobaugh DJ, Nnadi AK, Talwalkar JA. Determinants of palliative care utilization among patients hospitalized with metastatic gastrointestinal malignancies. Am J Hosp Palliat Care. 2017;34(3):269–274.CrossRefPubMed
14.
Merchant SJ, Lajkosz K, Brogly SB, Booth CM, Nanji S, Patel SV, et al. The final 30 days of life: a study of patients with gastrointestinal cancer in Ontario, Canada. J Palliat Care. 2017;32(3–4)92–100.CrossRefPubMed
15.
Merchant SJ, Brogly SB, Goldie C, Booth CM, Nanji S, Patel SV, et al. Palliative care is associated with reduced aggressive end-of-life care in patients with gastrointestinal cancer. Ann Surg Oncol. 2018;25(6):1478–87.CrossRefPubMed
16.
Clarke EA, Marrett LD, Kreiger N. Cancer registration in Ontario: a computer approach. IARC Sci Publ. 1991;(95):246–57.
17.
Li KK, Harris K, Hadi S, Chow E. What should be the optimal cut points for mild, moderate, and severe pain? J Palliat Med. 2007;10(6):1338–46.CrossRefPubMed
18.
Selby D, Cascella A, Gardiner K, Do R, Moravan V, Myers J, et al. A single set of numerical cutpoints to define moderate and severe symptoms for the edmonton symptom assessment system. J Pain Symptom Manag. 2010;39(2):241–9.CrossRef
19.
Hui D, Kilgore K, Fellman B, Urbauer D, Hall S, Fajardo J, et al. Development and cross-validation of the in-hospital mortality prediction in advanced cancer patients score: a preliminary study. J Palliat Med. 2012;15(8):902–9.CrossRefPubMedPubMedCentral
20.
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–9.CrossRefPubMed
21.
22.
Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005;162(3):199–200.CrossRefPubMed
23.
24.
Spoozak L, Seow H, Liu Y, Wright J, Barbera L. Performance status and symptom scores of women with gynecologic cancer at the end of life. Int J Gynecol Cancer. 2013;23(5):971–8.CrossRefPubMed
25.
Wong AKY. Referral patterns to palliative care: an inpatient snapshot study. J Clin Oncol. 2016;34(26 Suppl):119.CrossRef
26.
Morita T, Akechi T, Ikenaga M, Kizawa Y, Kohara H, Mukaiyama T, et al. Late referrals to specialized palliative care service in Japan. J Clin Oncol. 2005;23(12):2637–44.CrossRefPubMed
27.
Cherny N, Catane R, Schrijvers D, Kloke M, Strasser F. European society for medical oncology (ESMO) program for the integration of oncology and palliative care: a 5-year review of the designated centers’ incentive program. Ann Oncol. 2010;21(2):362–9.CrossRefPubMed
28.
Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, et al. Integration of palliative care into standard oncology care: American society of clinical oncology clinical practice guideline update. J Clin Oncol. 2017;35(1):96–112.CrossRefPubMed
29.
Barbera L, Seow H, Husain A, Howell D, Atzema C, Sutradhar R, et al. Opioid prescription after pain assessment: a population-based cohort of elderly patients with cancer. J Clin Oncol. 2012;30(10):1095–9.CrossRefPubMed
30.
Hui D, Shamieh O, Paiva CE, Perez-Cruz PE, Kwon JH, Muckaden MA, et al. Minimal clinically important differences in the edmonton symptom assessment scale in cancer patients: a prospective, multicenter study. Cancer. 2015;121(17):3027–35.CrossRefPubMed
31.
Hui D, Park M, Shamieh O, Paiva CE, Perez-Cruz PE, Muckaden MA, et al. Personalized symptom goals and response in patients with advanced cancer. Cancer. 2016;122(11):1774–81.CrossRefPubMed
32.
Shamieh O, Khamash O, Khraisat M, Jbouri O, Awni M, Al-Hawamdeh A, et al. Impact of outpatient palliative care (PC) on symptom burden in patients with advanced cancer at a tertiary cancer center in Jordan. Support Care Cancer. 2017;25(1):177–83.CrossRefPubMed
33.
Kang JH, Kwon JH, Hui D, Yennurajalingam S, Bruera E. Changes in symptom intensity among cancer patients receiving outpatient palliative care. J Pain Symptom Manag. 2013;46(5):652–60.CrossRef
34.
Nicholls SG, Langan SM, Benchimol EI. Routinely collected data: the importance of high-quality diagnostic coding to research. CMAJ Can Med Assoc. 2017;189(33):E1054–E5.CrossRef
Metadata
Title
Palliative Care and Symptom Burden in the Last Year of Life: A Population-Based Study of Patients with Gastrointestinal Cancer
Authors
Shaila J. Merchant, MSc, MHSc, MD, FRCSC, FACS
Susan B. Brogly, PhD
Christopher M. Booth, MD
Craig Goldie, MD
Sulaiman Nanji, MD, PhD
Sunil V. Patel, MSc, MD
Katherine Lajkosz, MSc
Nancy N. Baxter, MD, PhD
Publication date
01-08-2019
Publisher
Springer International Publishing
Keyword
Care
Published in
Annals of Surgical Oncology / Issue 8/2019
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07320-z

Other articles of this Issue 8/2019

Annals of Surgical Oncology 8/2019 Go to the issue

Breast Oncology

Multicenter Phase II Study of Intraoperative Radiotherapy of Early Breast Cancer: Ipsilateral Tumor Recurrence

Breast Oncology

Pretreatment Tattoo Marking of Suspicious Axillary Lymph Nodes: Reliability and Correlation with Sentinel Lymph Node

Endocrine Tumors

Papillary Thyroid Cancers with Focal Tall Cell Change are as Aggressive as Tall Cell Variants and Should Not be Considered as Low-Risk Disease

Breast Oncology

Oncoplastic Level 2 Mammoplasty for Large DCIS: 5-Year Results

Hepatobiliary Tumors

Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma

Gastrointestinal Oncology

Clinical Importance of Sputum in the Respiratory Tract as a Predictive Marker of Postoperative Morbidity After Esophagectomy for Esophageal Cancer